nitazoxanide has been researched along with Orthomyxoviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hurt, AC; Mifsud, EJ; Ming-Kay Tai, C; Oh, DY; Rossignol, JF; Tilmanis, D | 1 |
| Barr, IG; Hurt, AC; Koszalka, P; Mifsud, E; Rossignol, JF; Tilmanis, D | 1 |
2 other study(ies) available for nitazoxanide and Orthomyxoviridae Infections
| Article | Year |
|---|---|
Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy.
Topics: Administration, Oral; Animals; Antiviral Agents; Chemoprevention; Dogs; Drug Combinations; Drug Resistance, Viral; Female; Ferrets; Influenza A Virus, H1N1 Subtype; Lung; Madin Darby Canine Kidney Cells; Male; Nitro Compounds; Orthomyxoviridae Infections; Oseltamivir; Thiazoles; Virus Shedding | 2020 |
Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
Topics: Animals; Antiviral Agents; Cell Proliferation; Dogs; Drug Resistance, Viral; Drug Therapy, Combination; Female; Ferrets; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Male; Nitro Compounds; Orthomyxoviridae Infections; Oseltamivir; Thiazoles | 2020 |